R 1487

Drug Profile

R 1487

Alternative Names: R1487

Latest Information Update: 12 May 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antirheumatics
  • Mechanism of Action Phosphotransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 12 May 2004 Discontinued - Phase-I for Rheumatoid arthritis in Europe (unspecified route)
  • 22 Nov 2002 Phase-I clinical trials in Rheumatoid arthritis in Europe (unspecified route)
  • 11 Apr 2002 Preclinical trials in Rheumatoid arthritis in Europe (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top